Your browser doesn't support javascript.
loading
Targeting AKT in ER-Positive HER2-Negative Metastatic Breast Cancer: From Molecular Promises to Real Life Pitfalls?
Mery, Benoîte; Poulard, Coralie; Le Romancer, Muriel; Trédan, Olivier.
Affiliation
  • Mery B; Medical Oncology Department, Centre Léon Bérard, F-69000 Lyon, France.
  • Poulard C; Inserm U1052, Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France.
  • Le Romancer M; CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France.
  • Trédan O; Inserm U1052, Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France.
Int J Mol Sci ; 22(24)2021 Dec 16.
Article in En | MEDLINE | ID: mdl-34948307
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 / Phosphatidylinositol 3-Kinases / Proto-Oncogene Proteins c-akt Limits: Female / Humans Language: En Journal: Int J Mol Sci Year: 2021 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 / Phosphatidylinositol 3-Kinases / Proto-Oncogene Proteins c-akt Limits: Female / Humans Language: En Journal: Int J Mol Sci Year: 2021 Type: Article Affiliation country: France